Andrew S Protheroe

18PUBLICATIONS
169CO-AUTHORS
Predictive and prognostic markersMolecular targetsGenomicsGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Mar 12, 2026
Flourine-18 Prostate-Specific Membrane Antigen-1007 Positron Emission Tomography Imaging in Staging of Primary and Secondary Prostate Cancer-A Retrospective Observational Cohort Study.

Matthew H V Byrne, Nithesh Ranasinha, Abhishek Sharma

|Jul 28, 2025
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study.

Gianmarco Leone, Yien Ning Sophia Wong, Robert J Jones

|Oct 27, 2024
Genomic landscape of adult testicular germ cell tumours in the 100,000 Genomes Project.

Máire Ní Leathlobhair, Anna Frangou, Ben Kinnersley

|Apr 26, 2024
Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions.

Mark P Purdue, Diptavo Dutta, Mitchell J Machiela

|Oct 26, 2023
Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer.

Robert Hugh Jones, Karim Fizazi, Nicholas D James

|Aug 26, 2023
Genomic Evolution and Transcriptional Changes in the Evolution of Prostate Cancer into Neuroendocrine and Ductal Carcinoma Types.

Srinivasa R Rao, Andrew Protheroe, Lucia Cerundolo

Pageof 3

Frequent Collaborators

4 joint publications

Gerhardt Attard

4 joint publications

Robert J Jones

4 joint publications

Simon J Crabb

3 joint publications

Urbano Anido Herranz